Drug Shortage Report for KENALOG-10 INJECTION

Last updated on 2026-03-17

Report ID 260271
Drug Identification Number 01999761
Brand name KENALOG-10 INJECTION
Common or Proper name Triamcinolone Acetonide
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status MARKETED
Active Ingredient(s) TRIAMCINOLONE ACETONIDE
Strength(s) 10MG
Dosage form(s) SUSPENSION
Route of administration INTRASYNOVIAL INTRADERMAL INTRABURSAL INTRA-ARTICULAR INTRABURSAL INTRASYNOVIAL INTRADERMAL INTRA-ARTICULAR
Packaging size 5ML
Anatomical Therapeutical Chemical (ATC) code H02AB
Anatomical Therapeutical Chemical (ATC) description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-06-13
Actual start date 2025-06-13
Estimated end date 2026-04-30
Actual end date
Shortage status Actual shortage
Updated date 2026-03-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-10-16 French Compare
v8 2025-10-16 English Compare
v7 2025-08-21 French Compare
v6 2025-08-21 English Compare
v5 2025-08-21 French Compare
v4 2025-08-21 English Compare
v3 2025-06-14 English Compare
v2 2025-06-13 French Compare
v1 2025-06-13 English Compare

Showing 1 to 9 of 9